IL-36γ has been proposed to further regulate the anti-tumour immune response via tertiary lymphoid structure (TLS) formation, which are lymphoid organs composed of innate and adaptive immune cells which develop ectopically in inflamed tissues and can be associated with positive prognosis in cancer [75, 76]. The gene discussed is IL36G; the disease is cancer.